Endosomal Toll-like receptor signaling complex (Endosomal TLR signaling complex)

Endosomal Toll-like receptor (TLR) signaling complexes are specialized protein assemblies that form within the endolysosomal compartments of immune cells to detect pathogen-derived nucleic acids [3, 15]. This group includes TLR3, which recognizes double-stranded RNA, and TLR7, TLR8, and TLR9, which recognize single-stranded RNA and unmethylated CpG DNA [9, 14]. Upon activation, these receptors recruit specific adaptor proteins—TRIF for TLR3 and MyD88 for TLR7, TLR8, and TLR9—to assemble signaling hubs that include kinases such as IRAK4 and TBK1 [6, 13]. These complexes drive the production of type I interferons and pro-inflammatory cytokines, which are essential for antiviral defense but can cause pathology if chronically activated [11, 15]. In autoimmune diseases like systemic lupus erythematosus (SLE) and rheumatoid arthritis, these complexes are inappropriately triggered by self-nucleic acids, leading to persistent inflammation [4, 7]. Therapeutic strategies include the use of antimalarials like hydroxychloroquine to prevent endosomal activation, as well as novel small-molecule antagonists and kinase inhibitors designed to selectively disrupt these signaling pathways [1, 13]. Additionally, agonists of these complexes are being investigated as vaccine adjuvants and cancer immunotherapies to stimulate robust innate and adaptive immune responses [16, 17].

Other names

Nucleic acid-sensing TLR signaling complexesIntracellular TLR signaling complexesTLR3/7/8/9 signaling complexesEndolysosomal TLR signaling complexesMyddosomeTRIF-dependent signaling complex

Toll-like receptor antagonism, inhibition of endosomal acidification, IRAK4 kinase inhibition, and TRIF-mediated signaling inhibition.